N-(4-Methyl-3-(1-methyl-7-(4-methyl-3-(methylamino)-phenylamino)-2-oxo-1,2-dihydropyrimido[4,5-d]pyrimidin-3(4H)-yl)phenyl)-3-(trifluoromethyl)benzamide

ID: ALA3780021

Chembl Id: CHEMBL3780021

PubChem CID: 127030798

Max Phase: Preclinical

Molecular Formula: C30H28F3N7O2

Molecular Weight: 575.60

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CNc1cc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc2C)C3)ccc1C

Standard InChI:  InChI=1S/C30H28F3N7O2/c1-17-8-10-22(13-24(17)34-3)37-28-35-15-20-16-40(29(42)39(4)26(20)38-28)25-14-23(11-9-18(25)2)36-27(41)19-6-5-7-21(12-19)30(31,32)33/h5-15,34H,16H2,1-4H3,(H,36,41)(H,35,37,38)

Standard InChI Key:  IMYMZLGNJBCHNF-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3780021

    ---

Associated Targets(Human)

K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABL1 Tclin Bcr/Abl fusion protein (1667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABL1 Tclin Transcription factor ETV6/Tyrosine-protein kinase ABL1 (41 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 575.60Molecular Weight (Monoisotopic): 575.2257AlogP: 6.73#Rotatable Bonds: 6
Polar Surface Area: 102.49Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.53CX Basic pKa: 4.60CX LogP: 5.86CX LogD: 5.86
Aromatic Rings: 4Heavy Atoms: 42QED Weighted: 0.24Np Likeness Score: -1.51

References

1. Liang X, Liu X, Wang B, Zou F, Wang A, Qi S, Chen C, Zhao Z, Wang W, Qi Z, Lv F, Hu Z, Wang L, Zhang S, Liu Q, Liu J..  (2016)  Discovery of 2-((3-Amino-4-methylphenyl)amino)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)-4-(methylamino)pyrimidine-5-carboxamide (CHMFL-ABL-053) as a Potent, Selective, and Orally Available BCR-ABL/SRC/p38 Kinase Inhibitor for Chronic Myeloid Leukemia.,  59  (5): [PMID:26789553] [10.1021/acs.jmedchem.5b01618]

Source